Sensitive Cyp3a Substrates + Suzetrigine Interaction
Moderateinteraction on record
Description
Dosage modification of sensitive CYP3A substrates may be required when initiating or discontinuing JOURNAVX. JOURNAVX is a CYP3A inducer that may reduce exposure of CYP3A substrates.
Mechanism
Suzetrigine is a CYP3A inducer that reduces exposure of sensitive CYP3A substrates
Source: NLP:suzetrigine